Kevin T. Strange - Jan 1, 2025 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
Chief Financial Officer
Signature
/s/ Shannon Trevino, attorney-in-fact for Kevin T Strange
Stock symbol
NARI
Transactions as of
Jan 1, 2025
Transactions value $
-$52,939
Form type
4
Date filed
1/3/2025, 04:48 PM
Previous filing
Oct 3, 2024
Next filing
Feb 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Tax liability -$3.22K -63 -0.13% $51.05 47.3K Jan 1, 2025 Direct F1
transaction NARI Common Stock Tax liability -$7.61K -149 -0.32% $51.05 47.1K Jan 1, 2025 Direct F2
transaction NARI Common Stock Tax liability -$8.98K -176 -0.37% $51.05 47K Jan 1, 2025 Direct F3
transaction NARI Common Stock Tax liability -$11.6K -227 -0.48% $51.05 46.7K Jan 1, 2025 Direct F3
transaction NARI Common Stock Tax liability -$14.1K -276 -0.59% $51.05 46.5K Jan 1, 2025 Direct F4
transaction NARI Common Stock Tax liability -$7.45K -146 -0.31% $51.05 46.3K Jan 1, 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021.
F2 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022.
F3 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023.
F4 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024.